Zacks Private Picks

Click for the easiest, most affordable way to get the 'Best of Our Best.

Click for the easiest, most affordable way to get the 'Best of Our Best.

New Strong Buy Stocks for October 7th

This AI-powered knowledge hub designed to automate and enhance customer experiences has seen the Zacks Consensus Estimate for its current year earnings increase 52.2% over the last 60 days.

This AI-powered knowledge hub designed to automate and enhance customer experiences has seen the Zacks Consensus Estimate for its current year earnings increase 52.2% over the last 60 days.

PepsiCo Earnings Loom: Can Momentum Continue?

PEP shares have finally shown some life over the past three months, gaining nearly 6%. With the company on deck to report results this week, can the recent momentum follow through?

PEP shares have finally shown some life over the past three months, gaining nearly 6%. With the company on deck to report results this week, can the recent momentum follow through?

JPM Stock Before Q3 Earnings: Should You Buy Now or Wait for Results?

JPMorgan's Q3 earnings on Oct. 14 could show strength in trading and IB, but rising expenses and asset quality trends may test investors' resolve.

JPMorgan's Q3 earnings on Oct. 14 could show strength in trading and IB, but rising expenses and asset quality trends may test investors' resolve.

Buy 5 Gold Miner Stocks on Fed Rate Cut Hopes and Government Shutdown

Gold's record rally and rising Fed rate cut hopes are fueling gains for miners like AEM, DRD, AGI, GFI and USAU.

Gold's record rally and rising Fed rate cut hopes are fueling gains for miners like AEM, DRD, AGI, GFI and USAU.

AWS 10/7: Do AI Trees Grow to the Sky?

How much can OpenAI front-run its Stargate project, and how much more money can it borrow to finance these things in the near term?

How much can OpenAI front-run its Stargate project, and how much more money can it borrow to finance these things in the near term?

PFP 10/7: Stocks Closed Mostly Higher Yesterday, Tech-Heavy Nasdaq and Small-Cap Russell 2000 Make New All-Time Highs

Given the forecast for another strong earnings season, I'm expecting another positive performance from the market.

Given the forecast for another strong earnings season, I'm expecting another positive performance from the market.

Top Analyst Reports for Microsoft, Amazon.com & Johnson & Johnson

Microsoft rides AI and cloud growth, Amazon leans on AWS and Prime, and Johnson & Johnson gains from strong pharma momentum despite patent risks.

Microsoft rides AI and cloud growth, Amazon leans on AWS and Prime, and Johnson & Johnson gains from strong pharma momentum despite patent risks.

From Loss to Lift-Off: Marijuana ETFs Rebound on New Prospects

The outlook began shifting in July 2025, as news emerged that the U.S. federal government might reschedule cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act.

The outlook began shifting in July 2025, as news emerged that the U.S. federal government might reschedule cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act.